Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Change in Account Payables (2010 - 2012)

Bruker posted quarterly Change in Account Payables of -$6.8 million for Q2 2012, down 423.08% year-on-year from $2.1 million in Q3 2011, and down 162.96% on a QoQ basis from $10.8 million in Q1 2012.

Bruker (BRKRP) has 3 years of Change in Account Payables data on file, last reported at -$6.8 million in Q2 2012.

  • For the quarter ending Q2 2012, Change in Account Payables fell 423.08% year-over-year to -$6.8 million; the trailing twelve-month figure through Jun 2012 stood at $200000.0 (down 98.04% YoY), and the FY2025 full-year result was -$37.5 million, down 280.29% from the prior year.
  • Change in Account Payables for Q2 2012 stood at -$6.8 million, down from $10.8 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $14.3 million in Q1 2011 and bottomed at -$6.8 million in Q2 2012.
  • The 3-year median for Change in Account Payables is $100000.0 (2010), against an average of $2.0 million.
  • The widest annual swing landed in 2011, when Change in Account Payables jumped 142.37%; it then slumped 423.08% in 2012.
  • A 3-year view of Change in Account Payables shows it stood at -$4.3 million in 2010, then jumped by 44.19% to -$2.4 million in 2011, then slumped by 183.33% to -$6.8 million in 2012.
  • The last three Change in Account Payables figures came in at -$6.8 million (Q2 2012), $10.8 million (Q1 2012), and -$2.4 million (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -198.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 221.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 56.90 Mn
10 Bruker - - 379.80 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2012 -6.80 Mn
Jun 30, 2012 -6.80 Mn
Mar 31, 2012 10.80 Mn
Mar 31, 2012 10.80 Mn
Dec 31, 2011 -2.40 Mn
Dec 31, 2011 -2.40 Mn
Sep 30, 2011 -1.40 Mn
Sep 30, 2011 -1.40 Mn
Jun 30, 2011 -1.30 Mn
Jun 30, 2011 -1.30 Mn
Mar 31, 2011 14.30 Mn
Mar 31, 2011 14.30 Mn
Dec 31, 2010 -4.30 Mn
Dec 31, 2010 -4.30 Mn
Sep 30, 2010 1.50 Mn
Sep 30, 2010 1.50 Mn
Jun 30, 2010 3.40 Mn
Jun 30, 2010 3.40 Mn
Mar 31, 2010 5.90 Mn
Mar 31, 2010 5.90 Mn